Tetrapropylammonium → 3-Tert-butoxycarbonyl-5(S)-(2(S)-formyl-3-methyl-butyl)-4(S)-(2(S)-isopropyl-3-[4-methoxy-3-(3-methoxypropyloxy)phenyl]-propyl}-2,2-dimethyl-1,3-oxazolidine

HRID 264939Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 264939
C[N+]1([O-])CCOCC1.[C:9]([O:13][C:14]([N:16]1[C@@H:20]([CH2:21][C@@H:22]([CH:38]([CH3:40])[CH3:39])[CH2:23][C:24]2[CH:29]=[CH:28][C:27]([O:30][CH3:31])=[C:26]([O:32][CH2:33][CH2:34][CH2:35][O:36][CH3:37])[CH:25]=2)[C@H:19]([CH2:41][C@@H:42]([CH:45]([CH3:47])[CH3:46])[CH2:43][OH:44])[O:18][C:17]1([CH3:49])[CH3:48])=[O:15])([CH3:12])([CH3:11])[CH3:10].C([N+](CCC)(CCC)CCC)CC>ClCCl>[C:9]([O:13][C:14]([N:16]1[C@@H:20]([CH2:21][C@@H:22]([CH:38]([CH3:40])[CH3:39])[CH2:23][C:24]2[CH:29]=[CH:28][C:27]([O:30][CH3:31])=[C:26]([O:32][CH2:33][CH2:34][CH2:35][O:36][CH3:37])[CH:25]=2)[C@H:19]([CH2:41][C@H:42]([CH:43]=[O:44])[CH:45]([CH3:46])[CH3:47])[O:18][C:17]1([CH3:48])[CH3:49])=[O:15])([CH3:12])([CH3:11])[CH3:10]

Komponenten

5

Edukt 3

HCID 9559TetrapropylammoniumHCID 82029Methyl morpholine oxideHCID 236253313-Oxazolidinecarboxylic acid, 5-[(2S)-2-(hydroxymethyl)-3-methylbutyl]-4-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4S,5S)-

Produkt 1

HCID 236253323-Tert-butoxycarbonyl-5(S)-(2(S)-formyl-3-methyl-butyl)-4(S)-(2(S)-isopropyl-3-[4-methoxy-3-(3-methoxypropyloxy)phenyl]-propyl}-2,2-dimethyl-1,3-oxazolidine

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel

Versuchsvorschrift

100 g of molecular sieve (0.3 nm) and 16.6 g of N-methylmorpholine-N-oxide are added to 53 g of 3-tert-butoxycarbonyl-5(S)-(3-hydroxy-2(S)-isopropyl-propyl)-4(S)-{2(S)-isopropyl-3-[4-methoxy-3-(3-methoxypropyloxy)-phenyl]-propyl}-2,2-dimethyl-1,3-oxazolidine in 1.8 litres of dichloromethane at room temperature. The reaction mixture is stirred for 10 minutes and then 1.60 g of tetrapropylammonium perrutherate are added. The reaction mixture is stirred for a further 30 minutes and then filtered. The filtrate is diluted with dichloromethane and then washed in succession with 2M sodium sulfite solution, saturated sodium chloride solution and 1M copper(II) sulfate. The organic phase is concentrated by evaporation and the crude title compound is obtained: Rf (ethyl acetate/hexane=1:2)=0.43.

Aufarbeitung

  1. stirringThe reaction mixture is stirred for a further 30 minutes
  2. filtrationfiltered
  3. additionThe filtrate is diluted with dichloromethane
  4. washwashed in succession with 2M sodium sulfite solution, saturated sodium chloride solution and 1M copper(II) sulfate
  5. concentrationThe organic phase is concentrated by evaporation

Quellen und Nachweise

ORD-Eintrag
ord-bad37102171446dc8e98667866c5c2c5
Quelldatensatz
uspto-grants-1997_07
Patentnummer
US05646143

Notizen zur Reaktion

Wird geladen…